# Flaxseed Modulates Inflammation and Oxidative Stress in CF

> **NCT02014181** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 10 (actual)

## Conditions studied

- Cystic Fibrosis
- Oxidative Stress
- Inflammation

## Interventions

- **DIETARY_SUPPLEMENT:** finely ground flaxseed powder

## Key facts

- **NCT ID:** NCT02014181
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02014181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02014181, "Flaxseed Modulates Inflammation and Oxidative Stress in CF". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02014181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*